Monoclonal Antibodies in Headache: From Bench to Patient

Description of Monoclonal Antibodies in Headache: From Bench to Patient

Intended to promote a more appropriate and modern therapeutic approach to migraine management, this book is the first to deal with monoclonal antibodies in this context. Authored by the most respected migraine experts from around the globe and drawing on the lessons learned in both clinical trials and clinical practice, it reviews the current state of knowledge on this important therapeutic innovation, which has produced impressive data in randomized controlled trials, and the efficacy and safety of which have been confirmed in day-to-day real-world use. Given its scope, the book will appeal to a broad range of specialists, including pharmacologists, clinical pharmacologists, neurologists and internists, but also to residents and medical students.

About the Author

Antoinette Maassen van den Brink is an Associate Professor of Pharmacology at the Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands. Her main focus is on the neurovascular aspects of migraine, with a special interest in the impact of female sex hormones on the disease’s neurovascular pharmacology.

Paolo Martelletti has been an Associate Professor of Internal Medicine at the University ‘La Sapienza’ of Rome since 2005 and Director of the Regional Reference Centre for Headaches at Sant’Andrea Hospital in Rome, Italy, since 2003.

Read more about: Antoinette Maassen van den Brink, Paolo Martelletti